Biotech & Medtech
Biotech & Medtech news — Wednesday 04 November 2026
24 stories from 3 sources, every one in English. Each links to its publisher.
-
CVS Health Bids Goodbye to Vertical Integration But Not Conflict of Interest
MedCity News
CVS Health plans to split into two companies by 2028, but experts say the move may not resolve conflicts of interest between its insurance and PBM businesses. The post CVS Health Bids Goodbye to Vertical Integration But Not Conflict of…
-
Researchers Receive $4M NIH Grant to Build AI Model To Prevent Kidney Injury
MedCity News
Acute kidney injury is a common and sometimes serious surgical complication. Researchers at New York’s Mount Sinai health system are building AI models to better predict who’s most at risk, so that healthcare providers can offer…
-
STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill
STAT News
WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a key funding source for the Food and Drug Administration, in part by empowering a major critic of the…
-
STAT+: Mass. marijuana consumers, workers high on victory after repeal of recreational weed sales fails in a rout
STAT News
Puff, puff, didn’t pass. It was a night of relieved exhaling for weed consumers and industry workers across Massachusetts, as voters decisively shot down Question 8 , a ballot initiative that would have dismantled the state’s recreational…
-
Servier Stumbles in Muscle Disease as Drug From $1.5B Deal Fails Pivotal Test
MedCity News
Servier’s sevasemten came from the acquisition of the muscular dystrophy assets of Edgewise Therapeutics. While the small molecule had met the goal of a Phase 2 test in Becker muscular dystrophy, Servier said new results in a pivotal…
-
STAT+: Democratic doctors and scientists ride the blue wave
STAT News
Democratic physicians, nurses, and scientists won dramatic victories across the U.S. on Tuesday, part of the sweeping blue wave that saw Democrats regain control of Congress in midterm elections that spotlighted health care, public health…
-
Sanofi stops development of Nurix-partnered immune drug
BioPharma Dive
The decision sparked a sell-off in Nurix shares as well as analyst debate about the prospects of drugs designed to degrade a tough-to-reach protein called STAT6.
-
STAT+: Where does MAHA go from here? 3 possible futures
STAT News
WASHINGTON — Reports of the Make America Healthy Again movement’s demise have been exaggerated. Or have they? The fate of the young coalition, helmed by health secretary Robert F. Kennedy Jr., hangs in the balance after Tuesday’s midterm…
-
STAT+: CVS Health to split, reversing years of deal-making to combine pharmacies and insurance
STAT News
CVS Health will split into two separate companies , unraveling decades of deals that turned CVS into one of the largest health care conglomerates in the country. Both of the new publicly traded companies will still have CVS in their names…
-
Novo gets much-needed lift as Wegovy pill tops Wall Street forecasts
BioPharma Dive
The drug’s third-quarter sales numbers came in well above consensus estimates, widening Novo’s early edge over Eli Lilly in the latest battleground for weight loss medicines.
-
STAT+: A looming deadline to fund the government will shape Congress’ unusual lame duck session
STAT News
WASHINGTON — Democrats decisively won control of the House and Senate , but Republicans are still in charge until next year, and Congress has until Dec. 11 to pass a bill to fund the government. Those are the dynamics determining what’s…
-
CVS to split into two companies in stunning strategic about-face
BioPharma Dive
The breakup, which will separate Aetna and Caremark from CVS’ retail pharmacies, is an indictment of the dogma that bigger is always better in the healthcare industry.
-
Biopharma likely to climb higher after ‘blue wave,’ analysts say
BioPharma Dive
Historical data suggests the sector outperforms after midterm elections. And Democrats, newly in control of Congress, have “bigger fish to fry” than drug pricing, analysts said.
-
STAT+: Five midterm winners and losers: MAHA mowed down, Dem docs scrub in, Medicare for All returns
STAT News
Regaining control of both the Senate and House Tuesday night put Democrats in position to stymie and possibly reverse parts of President Trump’s health care agenda, and delivered a potentially fatal blow to health secretary Robert F…
-
When Patients Become Consumers: The New Care Stack Collides With Legacy Healthcare
MedCity News
To succeed, our healthcare system must fully embrace consumer-focused product design to address demands of scale, access, and daily usability that the market is revealing. The post When Patients Become Consumers: The New Care Stack…
-
STAT+: Ultragenyx cuts staff after another study fails
STAT News
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We’re breaking down the election results — let’s get straight to it. The need-to-know this morning…
-
Breast Cancer Survivorship Is a Menopause Problem Nobody Owns
MedCity News
For all the pink ribbons we see, women with breast cancer are abandoning one of the most effective treatments they have because of symptoms no one in their care team is clearly responsible for. The post Breast Cancer Survivorship Is a…
-
STAT+: Pharmalittle: We’re reading about CVS plans to split up, FDA inspections in India and China and more
STAT News
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While…
-
STAT+: Sens. Wyden and Sanders, backers of Medicare for All, set to take charge of key committees
STAT News
WASHINGTON — The Democratic flip of the Senate is expected to put two Democrats who support “Medicare for All” in charge of key committees. Sen. Ron Wyden (D-Ore.) is expected to lead the Finance Committee, and Sen. Bernie Sanders (I-Vt.)…
-
STAT+: The biotech startups skipping AI for drug discovery
STAT News
This is the web edition of STAT’s AI Prognosis newsletter, our guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. “For my 24th birthday, my friends and I spent 3 days in…
-
STAT+: Former Madrigal Pharmaceuticals executive alleges coverup of safety issues tied to its drug
STAT News
A top former executive at Madrigal Pharmaceuticals has filed a lawsuit in federal court alleging he was forced to resign after raising internal concerns about the safety of the company’s approved medication for patients with the liver…
-
Top health takeaways from the midterm elections
STAT News
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here . Good morning from a round-the-clock elections team at STAT, where we’ve been closely monitoring Election Day results…
-
Opinion: I moved to Europe for free health care. I miss my patient portal
STAT News
Tuesday, at exactly 7 a.m., I arrived at my general practitioner’s office, in the basement level of his house, two blocks from mine in Mellieħa, Malta. There are six chairs in the waiting area. Ikea, I think. People note who got there…
-
STAT+: Democrats win power to push back on Trump’s health care moves
STAT News
WASHINGTON — Democrats broke the Republican trifecta of power in Washington Tuesday night, securing powerful new tools to push back on the Trump administration’s health agenda. Voters granted Democrats control of both chambers of Congress…